Current market catalysts

Leerink Partners Maintains Outperform on Pharvaris, Raises Price Target to $65

Researchers Say OpenAI's Rogue Agents Used At Least 10 Additional Sites For Unauthorized Communications Beyond German Wiki Identified Last Week

Leerink Partners Maintains Outperform on Merck & Co, Raises Price Target to $161

8-K filing — SYSCO CORP (SYY)

Filed: 2026-09-09 AccNo: 0000950142-26-002526 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Alibaba Deploys Cross-Platform AI Agents to Drive Global Enterprise Expansion

Alibaba upgraded its QoderWake enterprise AI platform and integrated its domestic 1688 and global wholesale units despite fresh U.S. security scrutiny over AI distillation.

Here’s How Much You Would Have Made Owning Clean Harbors Stock In The Last 10 Years

Clean Harbors (NYSE:CLH) has outperformed the market over the past 10 years by 7.69% on an annualized basis producing an average annual return of 21.27%. Currently, Clean Harbors has a market capitalization of $16.74

What's Going On With Snap Stock Wednesday?

Snap Inc. (SNAP) stock dropped over 3% to $5.25 amid a broader market sell-off. Key support sits at $4.50 with technical resistance at $6.

Optical Cable Q3 2026 Earnings Call Transcript

Optical Cable (NASDAQ:OCC) held its third-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our

Trump's 'Made In America' Bitcoin Mining Pledge Is Falling Apart: What's Going On?

Trump’s U.S. Bitcoin mining pledge is unraveling as miners shift energy to AI, while China and Russia regain computing share amid weaker economics.

34 Years After Breaking the Bank, Bessent Bets the House

Treasury secretaries typically serve to soothe the markets, not taunt them. Yet, Scott Bessent chose the latter. Speaking at Southern Methodist University this week, he warned traders. "I am the house now, so

Leerink Partners Maintains Outperform on Evommune, Lowers Price Target to $22

Leerink Partners analyst Thomas Smith maintains Evommune (NYSE:EVMN) with a Outperform and lowers the price target from $28 to $22.

SpaceX shares are trading lower after the company reached a 90-day early-release milestone, unlocking approximately 319 million shares for sale.

8-K filing — Federal Home Loan Bank of Chicago

Filed: 2026-09-09 AccNo: 0001331451-26-000166 Size: 199 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Why Is Braze Stock Sinking Wednesday?

Why Is SK Hynix Stock Surging on Wednesday?

Korn Ferry Shares Slip, Strong Quarter Meets Weaker Q2 Earnings Guidance

Korn Ferry Stock falls despite an earnings and sales beat as Q2 adjusted EPS guidance trails estimates.

$1000 Invested In Waste Connections 15 Years Ago Would Be Worth This Much Today

Waste Connections (NYSE:WCN) has outperformed the market over the past 15 years by 1.03% on an annualized basis producing an average annual return of 14.05%. Currently, Waste Connections has a market capitalization of

Leerink Partners Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $20

Zenta Group Shares Halted On Circuit Breaker To The Upside; Stock Now Up 44.12%

Trump Administration Official Speaking On Fox Business Says Treasury Buyback Increase Is Part Of Ongoing Approach

Leerink Partners Initiates Coverage On Teva Pharmaceutical Indus with Outperform Rating, Announces Price Target of $45

Leerink Partners Initiates Coverage On Phathom Pharmaceuticals with Market Perform Rating, Announces Price Target of $10

GameStop shares are trading higher. Yesterday the company reported better-than-expected Q2 sales results.

AI Demand Surges: Dell Refinances Debt Following Massive Sales Forecast Hike

Dell Technologies plans a $4B bond sale to refinance debt, capitalizing on strong AI server demand and a upgraded annual sales forecast.

BTIG Maintains Buy on J.Jill, Raises Price Target to $25

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

MannKind licenses Technosphere GLP-1 tech to Rose Pharma for weight management development.

Pulse Biosciences shares are trading higher after Freedom Capital Markets initiated coverage on the stock with a Buy rating and announced a $73 price target.

BTIG Reiterates Buy on Opus Genetics, Maintains $12 Price Target

Zenta Group Inks Agreement To Acquire ZentoAI Intelligent Technology For HK$10M In Cash, $5.844M In Form Class A Shares

If You Invested $1000 In ATI Stock 10 Years Ago, You Would Have This Much Today

ATI (NYSE:ATI) has outperformed the market over the past 10 years by 15.93% on an annualized basis producing an average annual return of 29.51%. Currently, ATI has a market capitalization of $28.09 billion. Buying